Issued Patents All Time
Showing 25 most recent of 28 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12391747 | Type XXIII collagen assay | Tina Manon-Jensen, Shu Sun, Joachim Høg Mortensen | 2025-08-19 |
| 12383603 | Markers useful in enrichment strategies for the treatment of osteoarthritis | Christoph H. Ladel, Hans Guehring, Anne-Christine Bay-Jensen, Per Qvist | 2025-08-12 |
| 12366582 | Collagen type X alpha-1 assay | Yi He, Anne-Cecilie Bay-Jensen | 2025-07-22 |
| 12332250 | Inflammatory biomarkers for predicting responsiveness to FGF-18 compound | Christoph H. Ladel, Hans Guehring, Anne-Christine Bay-Jensen, Per Qvist | 2025-06-17 |
| 12332251 | Metabolic biomarkers for predicting responsiveness to FGF-18 compound | Christoph H. Ladel, Hans Guehring, Anne-Christine Bay-Jensen, Per Qvist | 2025-06-17 |
| 11531028 | Collagen type X alpha-1 assay | Anne-Christine Bay-Jensen, Yi He | 2022-12-20 |
| 11513128 | Metabolic biomarkers for predicting responsiveness to FGF-18 compound | Christoph H. Ladel, Hans Guehring, Anne-Christine Bay-Jensen, Per Qvist | 2022-11-29 |
| 11467169 | Inflammatory biomarkers for predicting responsiveness to FGF-18 compound | Christoph H. Ladel, Hans Guehring, Anne-Christine Bay-Jensen, Per Qvist | 2022-10-11 |
| 10350272 | Calcitonin analogues for treating diseases and disorders | Kim Henriksen, Kim Vietz Andreassen, Sofie Gydesen, Sara Toftegaard Hjuler | 2019-07-16 |
| 10267809 | Biochemical markers for CVD risk assessment | Natasha Barascuk Michaelsen, Per Qvist | 2019-04-23 |
| 10239929 | Peptide analogs for treating diseases and disorders | Nozer M. Mehta, William Stern, Amy Sturmer, Kim Henriksen | 2019-03-26 |
| 10232021 | Calcitonin mimetics for treating diseases and disorders | Kim Henriksen, Kim Vietz Andreassen | 2019-03-19 |
| 10001490 | Biochemical markers for pulmonary and other diseases | Jacob Hull Kristensen, Diana Julie Oersnes-Leeming | 2018-06-19 |
| 9891234 | Biochemical markers for CVD risk assessment | Natasha Barascuk Michaelsen, Federica Genovese, Diana Julie Leeming | 2018-02-13 |
| 9880177 | Fibrosis biomarker assay | Sanne S. Veidal, Diana Julie Oersnes-Leeming, Natasha Barascuk Michaelsen, Helene Skjot-Arkil, Antonio Segovia-Silvestre +1 more | 2018-01-30 |
| 9862754 | Peptide analogs for treating diseases and disorders | Nozer M. Mehta, William Stern, Amy Sturmer, Kim Henriksen | 2018-01-09 |
| 9835631 | Combined biomarker measurement of fibrosis | Federica Genovese, Mette Juul Nielsen, Lise Larsen, Diana Julie Oersnes-Leeming | 2017-12-05 |
| 9733260 | Biochemical markers for neurodegenerative conditions | Natasha Barascuk Michaelsen, Kim Henriksen | 2017-08-15 |
| 9726674 | PIIINP neo-epitope assay | Diana Julie Leeming, Mette Juul Nielsen | 2017-08-08 |
| 9606130 | Fibrosis biomarker assay | Sanne S. Veidal, Diana Julie Oersnes-Leeming, Natasha Barascuk Michaelsen, Helene Skjot-Arkil, Antonio Segovia-Silvestre +1 more | 2017-03-28 |
| 9533022 | Peptide analogs for treating diseases and disorders | Nozer M. Mehta, William Stern, Amy Sturmer, Kim Henriksen | 2017-01-03 |
| 9500659 | In vitro assessment of cardiovascular events by assay for neo-eptitopes of titin protein | Diana Julie Leeming, Efstathios Vassiliadis | 2016-11-22 |
| 9459260 | Detection of diagnostic peptides | Diana Julia Leeming, Efstathios Vassiliadis | 2016-10-04 |
| 9404932 | Pathology biomarker assay | Sanne S. Veidal, Diana Julie Leeming, Natasha Barascuk, Helene Skjøt-Arkil, Efstathios Vassiliadis | 2016-08-02 |
| 9359633 | Biochemical markers for CVD risk assessment | Per Qvist, Natasha Barascuk | 2016-06-07 |